BenK Tuesday, 05/14/19 12:16:22 PM Re: None Post # of 49350 "I had invested in the Promise of the science. What I should have paid attention to was the absolute horror of the business acumen..." A pretty familiar theme to all of us, right? What's interesting is that the above was posted last week on the message board of a different company. This company was trading in the very low pennies, and management did a 500 to 1 reverse split, hoping to get listed on the NASDAQ. Since then, the stock has gone down steadily, and unless something changes, it will probably end up back in the pennies, and go bankrupt. It will then end up as a private entity, or just disappear. What's noteworthy for us in that the CEO of that company is... David Dodd. This was his next move after Medizone. I'm not rushing to judgment. On the one hand, Dodd was awarded a handsome settlement from the legal battles that preceded his stint at Medizone, so apparently those allegations proved innacurate. On the other hand, his efforts since then haven't exactly come up roses. A very cloudy picture.